Literature DB >> 19375524

Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis.

Yang Sun1, Tian-Tian Cai, Xiao-Bin Zhou, Qiang Xu.   

Abstract

In the present study, we aimed at examining the immunosuppressive activity of saikosaponin a, a triterpene saponin derived from Bupleurum falcatum L. (Umbelliferae), and the underlying mechanisms. Saikosaponin a significantly inhibited the proliferation and activation of T cells activated by concanavalin A (Con A) in a concentration-dependent manner. Additionally, it potently suppressed Con A-stimulated IL-2, IFN-gamma and TNF-alpha production in mouse T cells. Saikosaponin a also caused G0/G1 arrest of activated T cells through down-regulating the protein levels of CDK6 and Cyclin D3 and up-regulating the protein level of p27(kip). Furthermore, the compound dose-dependently induced apoptosis of Con A-activated T cells rather than those non-activated, as determined by Annexin V/PI staining. Besides, it induced a remarkable collapse of mitochondrial membrane potential and caused significant release of cytochrome c from mitochondria to cytosol. In summary, these results suggest that the G0/G1 arrest as well as the induction of apoptosis via mitochondrial pathway are involved in the immunosuppressive activity of saikosaponin a against activated T cells. This may herald a novel approach for further studies of saikosaponin a as a candidate for the treatment of inflammatory and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375524     DOI: 10.1016/j.intimp.2009.04.006

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  22 in total

1.  Saikosaponin A protects against experimental sepsis via inhibition of NOD2-mediated NF-κB activation.

Authors:  Haiyan Zhao; Shuping Li; Haisheng Zhang; Gang Wang; Gaolei Xu; Hongbo Zhang
Journal:  Exp Ther Med       Date:  2015-06-10       Impact factor: 2.447

2.  Saikosaponin-d attenuates ventilator-induced lung injury in rats.

Authors:  Hong-Wei Wang; Ming Liu; Tai-Di Zhong; Xiang-Ming Fang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  Saikosaponins: a potential treatment option for systemic lupus erythematosus.

Authors:  G-C Wu; H Wu; L-Y Fan; H-F Pan
Journal:  Ir J Med Sci       Date:  2010-11-26       Impact factor: 1.568

4.  Neovascular glaucoma regulation by arylsulfonyl indoline-benzamide (ASIB) through targeting NF-kB signalling pathway.

Authors:  Xiaojun Lei; Yongxia Zhao
Journal:  3 Biotech       Date:  2019-05-10       Impact factor: 2.406

5.  Saponins as cytotoxic agents: a review.

Authors:  Irma Podolak; Agnieszka Galanty; Danuta Sobolewska
Journal:  Phytochem Rev       Date:  2010-06-25       Impact factor: 5.374

6.  Attenuation of neuropathic pain by saikosaponin a in a rat model of chronic constriction injury.

Authors:  Xin Zhou; Hong Cheng; Dedong Xu; Qing Yin; Lei Cheng; Lei Wang; Shasha Song; Mengyuan Zhang
Journal:  Neurochem Res       Date:  2014-08-09       Impact factor: 3.996

7.  Mitochondria-dependent apoptosis of con A-activated T lymphocytes induced by asiatic acid for preventing murine fulminant hepatitis.

Authors:  Wenjie Guo; Wen Liu; Shaocheng Hong; Hailiang Liu; Cheng Qian; Yan Shen; Xuefeng Wu; Yang Sun; Qiang Xu
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

Review 8.  Putative genes involved in saikosaponin biosynthesis in Bupleurum species.

Authors:  Tsai-Yun Lin; Chung-Yi Chiou; Shu-Jiau Chiou
Journal:  Int J Mol Sci       Date:  2013-06-19       Impact factor: 5.923

Review 9.  Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bokyung Sung; Ramaswamy Kannappan; Bharat B Aggarwal
Journal:  Toxins (Basel)       Date:  2010-10-22       Impact factor: 4.546

10.  Protein kinase C signaling and cell cycle regulation.

Authors:  Adrian R Black; Jennifer D Black
Journal:  Front Immunol       Date:  2013-01-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.